ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank W. Sellke
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, J.
Right arrow Articles by Sellke, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, J.
Right arrow Articles by Sellke, F. W.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2004;77:1384-1389
© 2004 The Society of Thoracic Surgeons


Original article: cardiovascular

Improved profile of bad phosphorylation and caspase 3 activation after blood versus crystalloid cardioplegia

Jun Feng, MD, PhDa, Cesario Bianchi, MD, PhDa, Jianyi Li, MDa, Frank W. Sellke, MDa*

a Division of Cardiothoracic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

Accepted for publication September 10, 2003.

* Address reprint requests to Dr Sellke, Division of Cardiothoracic Surgery, BIDMC, LMOB 2A, 110 Francis St, Boston, MA 02215, USA.
e-mail: fsellke{at}caregroup.harvard.edu

BACKGROUND: Expression of Bcl-2 family proteins and activation of terminal caspase 3 are important for ischemia-reperfusion-induced apoptosis. Bad and Bax are pro-apoptotic proteins, whereas, phosphorylation of Bad inhibits its binding to and inactivation of anti-apoptotic Bcl-2. Thus, decreases in phospho-Bad would be proapoptotic. We investigated if blood (BCP) or crystalloid cardioplegia (CCP) differentially affects apoptosis gene-related proteins.

METHODS: Rabbit hearts were perfused with Krebs-Henseleit buffer (KHB) on a Langendorff apparatus. Control hearts (n = 6) were perfused for 90 minutes without cardioplegic ischemia. In the other two groups, hearts were arrested for 30 minutes (37°C) with BCP (n = 6) or with CCP (n = 6) administered continuously (1.5 mL/min). The hearts were reperfused for 30 minutes with KHB. Left ventricle (LV) performance was measured before cardioplegic arrest and at 30 minutes of reperfusion. In vitro relaxation responses of precontracted microvessels (100–180 µm) were obtained in a pressurized no-flow state. Total and activated or phosphorylated caspase 3, Bcl-2, Bad, and Bax were measured by quantitative immunoblotting using specific antibodies.

RESULTS: Blood cardioplegia significantly improved the recovery of LV developed pressure compared to CCP (p < 0.05). The endothelium-dependent relaxation in response to adenosine 5'-diphosphate was greater after BCP than after CCP (59.9 ± 4% vs 26.9 ± 6%, respectively; p < 0.05). There were no differences in total protein levels of caspase 3, Bcl-2, Bad, and Bax between the groups. Both BCP and CCP increased caspase 3 activity as compared with controls, but CCP caused more activation of caspase 3 than BCP (6.2 ± 0.7 fold vs 3.1 ± 0.4, p < 0.05). Both BCP and CCP induced phosphorylation of Bad at Ser112, but BCP caused greater phosphorylation of Bad (3.5 ± 0.2 fold vs 2.0 ± 0.12 fold, respectively, p < 0.05) than CCP.

CONCLUSIONS: Blood cardioplegia is superior to CCP in inhibiting the activation of caspase 3 and in increasing phospho-Bad. These actions of BCP were associated with improved LV function and endothelium-dependent relaxation of coronary microvessels. These results may provide molecular mechanisms by which to improve myocardial protection during cardiac surgery.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. R. Khabbaz, J. Feng, M. Boodhwani, R. T. Clements, C. Bianchi, and F. W. Sellke
Nonischemic myocardial acidosis adversely affects microvascular and myocardial function and triggers apoptosis during cardioplegia
J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Boodhwani, J. Feng, S. Mieno, B. Ramlawi, N. Sodha, R. Clements, and F. W. Sellke
Effects of purified poloxamer 407 gel on vascular occlusion and the coronary endothelium.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 736 - 741.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Vahasilta, A. Saraste, V. Kyto, M. Malmberg, J. Kiss, E. Kentala, M. Kallajoki, and T. Savunen
Cardiomyocyte Apoptosis After Antegrade and Retrograde Cardioplegia
Ann. Thorac. Surg., December 1, 2005; 80(6): 2229 - 2234.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.